BioPharma Credit PLC
BOPCF
$0.96
$0.011.00%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.59M | 12.59M | 4.31M | 4.31M | 5.62M |
| Total Receivables | 53.60M | 53.60M | 54.67M | 54.67M | 31.80M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 66.19M | 66.19M | 58.98M | 58.98M | 37.42M |
|
|
|||||
| Total Current Assets | 66.19M | 66.19M | 58.98M | 58.98M | 37.42M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.17B | 1.17B | 1.16B | 1.16B | 1.20B |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 17.56M | 17.56M | 7.49M | 7.49M | 16.94M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 946.00K |
| Total Other Current Liabilities | -- | -- | -- | -- | 946.00K |
| Total Current Liabilities | 17.56M | 17.56M | 7.49M | 7.49M | 17.88M |
|
|
|||||
| Total Current Liabilities | 17.56M | 17.56M | 7.49M | 7.49M | 17.88M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | 55.00K |
| Total Liabilities | 17.56M | 17.56M | 7.49M | 7.49M | 17.94M |
|
|
|||||
| Common Stock & APIC | 620.86M | 620.86M | 620.86M | 620.86M | 620.86M |
| Retained Earnings | 530.00M | 530.00M | 529.45M | 529.45M | 560.81M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.15B | 1.15B | 1.15B | 1.15B | 1.18B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.15B | 1.15B | 1.15B | 1.15B | 1.18B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.15B | 1.15B | 1.15B | 1.15B | 1.18B |
|
|
|||||